Using baseline data from a clinical trial of domagrozumab in Duchenne muscular dystrophy, we evaluated the correlation between functional measures and quantitative MRI assessments of thigh muscle. Analysis included timed functional tests, knee extension/strength and North Star Ambulatory Assessment. Patients (n = 120) underwent examinations of one thigh, with MRI sequences to enable measurements of muscle volume (MV), MV index, mean T2 relaxation time via T2-mapping and fat fraction. MV was moderately correlated with strength assessments. MV index, fat fraction and T2-mapping measures had moderate correlations ( ∼ 0.5) to all functional tests, North Star Ambulatory Assessment and age. The moderate correlation between functional tests, age and baseline MRI measures supports MRI as a biomarker in Duchenne muscular dystrophy clinical trials. Trial registration: ClinicalTrials.gov, NCT02310763; registered 4 November 2014.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253163 | PMC |
http://dx.doi.org/10.2217/bmm-2020-0801 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!